Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar;18(3):389-392.
doi: 10.1002/alz.12633. Epub 2022 Mar 4.

"Exceptions that prove the rule"-Why have clinical trials failed to show efficacy of risk factor interventions suggested by observational studies of the dementia-Alzheimer's disease syndrome?

Affiliations
Editorial

"Exceptions that prove the rule"-Why have clinical trials failed to show efficacy of risk factor interventions suggested by observational studies of the dementia-Alzheimer's disease syndrome?

John C S Breitner et al. Alzheimers Dement. 2022 Mar.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proposed triaxial classification of factors that may modify outcomes in the dementia–AD syndrome

References

    1. Peters R, Breitner J, James S, et al. Dementia risk reduction: why haven’t the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors. Alzheimer’s & dementia : translational research & clinical interventions. 2021;7(1):e12202. - PMC - PubMed
    1. Peters R, Dodge HH, James S, et al. The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven’t lived up to expectations, and where do we go from here? Alzheimers Dement. 2021. - PubMed
    1. Cock A, Forsdyke DR. Treasure Your Exceptions: The Science and Life of William Bateson. New Yrok: Springer; 2008.
    1. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69(24):2197–2204. - PubMed
    1. Rabinovici GD, Carrillo MC, Forman M, et al. Multiple comorbid neuropathologies in the setting of Alzheimer’s disease neuropathology and implications for drug development. Alzheimer’s & dementia : translational research & clinical interventions. 2017;3(1):83–91. - PMC - PubMed

Publication types